Waverley Pharma Inc (WAVE : TSX-V)
Common Stock
$0.01
CAD
-0.01 (-25.00%)
Last updated: 2026-09-04
Get WAVE alerts:
WAVE
Waverley Pharma Inc
Performance
1 Day
+0.00%
1 Week
-25.00%
1 Month
+0.00%
YTD
-40.00%
Key Statistics
Market Cap
$810,000
52W High
$0.03
52W Low
$0.01
P/E Ratio
0.00
50 Day MA
$0.02
200 Day MA
$0.02
Beta
1.22
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 9/4/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 20,000 |
| 8/31/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 32,000 |
| 8/19/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 10,000 |
| 8/11/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 1,000 |
| 7/24/2026 | $0.02 | $0.02 | $0.01 | $0.01 | $0.01 | 7,500 |
| 7/21/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 24,000 |
| 7/3/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 0 |
| 6/23/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 1,730 |
| 6/22/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 2,500 |
| 6/8/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 7,456 |
Analyst Price Targets
Based on analyst covering WAVE
Wall Street analysts forecast WAVE stock price to rise 66566.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$10.00
+66566.7% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WAVE's historical volatility
30-Day Vol
511.2%
Annualized
90-Day Vol
511.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.00 – C$0.08 |
| 60 trading days | C$0.01 | C$0.00 – C$0.16 |
| 90 trading days | C$0.01 | C$0.00 – C$0.27 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Waverley Pharma Inc
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
Financials
- Revenue (TTM)
- $1.17M
- EBITDA
- $-503,738
- Profit Margin
- -63.40%
- ROE (TTM)
- -136.53%
- EPS (Diluted)
- 0.00
- Book Value
- -0.05
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About WAVE
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| CES-P | Celestial Acquisition Corp. | $0.20 | +185.71% |
| DDD | Metavista3D Inc. | $0.36 | +78.05% |
| SHRX | Sharp Therapeutics Corp. | $1.37 | +50.55% |
| SRA | Stria Lithium Inc | $1.15 | +47.44% |
| ATR-P | Aster Acquisition Corp. | $0.10 | +46.15% |
| RKV | Rakovina Therapeutics Inc | $0.32 | +45.45% |
| AAAJ-P | AAJ Capital 3 Corp. | $0.04 | +40.00% |
| FRNT | FRNT Financial Inc | $0.06 | +37.50% |
WAVE.V news timeline
5 articles covering WAVE.V, most recent first
Latest